Therapeutic expertise.
We have extensive industry experience that we leverage to unlock, activate and optimize value for your therapy at each pivotal moment.
An unrivalled depth and diversity of expertise.
Our deep therapeutic experience across a wide range of specialist areas enables us to bring rich, global subject matter expertise, scientific excellence, and diverse perspectives to your product.
With best-in-class capabilities and unrivalled depth and diversity of expertise, we’re the trusted partner for the most complex science and commercialization pathways in the industry.
Collaborating with clients to advance life-saving oncology treatments.
With over 30 years of experience and our position at the forefront of therapeutic advancements, we collaborate with biopharma clients to advance cancer treatments and improve patient outcomes.
Other specialist therapy areas.
We provide unparalleled access to a diverse knowledge base that supports the most high-value, critical path projects at each pivotal step on the journey to patients. In the last two years alone, we’ve helped innovators advance their assets across our specialist therapy areas including:
-
Central Nervous System (CNS)
Our CNS expertise has driven 45% of NME launches in two years, shapes 75% of top CNS products, and covers 58% of the market, showcasing our pivotal role in neuroscience.
-
Immunology
Over the last two years, we have influenced 80% of the top immunology products, supported 62% of NME launches, and achieved 88% market coverage, while working on 34% of marketed assets.
-
Blood
In the last two years, we been a pivotal force in the blood sector securing a 67% market coverage, supporting on 70% of the top 20 blood products, demonstrating a significant impact and presence.
-
Respiratory
In the last two years, we have breathed life into the respiratory sector, working on 70% of the top 20 products and achieving a 65% sweep in total market coverage, illustrating our vital presence in the field.
-
Anti-infectives
Our experience in Anti-infectives is clear with a 63% market coverage and a significant 60% involvement in the top anti-infective products, reflecting our innovative and impactful contributions to the field.
-
Gastro
In the last two years, we have championed 33% of Gastro-Intestinal NME launches, supported on 40% of the top 20 Gastro-Intestinal products, and continue to maintain a strong presence in this therapy area.
Sectors we serve.
We’re trusted by the best in the industry to activate meaningful growth and deliver sustainable, consistent, and lasting results throughout the entire commercialization journey.
From small to large pharma, biotech to healthcare providers and more, we understand your sector’s unique needs and are equipped with the knowledge and resources you need, precisely when you need them.
It's time to reimagine health.
Powered by data and technology, we bring you a breadth of connected expertise, dynamic creativity and scientific excellence in perfect harmony to help you on your journey to patients.
-
Read more
Assessing the commercial potential of an asset in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Making informed clinical and commercial decisions can help to optimize the value of an asset for pharmaceutical companies.
-
Read more
Assessing the commercial potential of an asset in Tourette’s Syndrome
SmartAnalyst was set the task to evaluate the commercial opportunity for a potential asset in Tourette’s Syndrome.
-
Read more
Creating a global scientific and communications narrative for new class of MS biological
A global narrative was required to tell the scientific story for a client launching a new class of multiple sclerosis monoclonal antibody treatment.
-
Read more
Creating a global enterprise solution for the introduction of a new vaccine
A major pharma and biotech company needed our help to support their vaccine in over 40 countries across the US, Europe, the Middle East, and Asia.
Your market-leading commercialization partner.
Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.